Showing results (241-250 of 287) with videos related to
Sort By:
Pageof 29
Neurology(R) Neuroimmunology & Neuroinflammation|April 12, 2022
Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSDJiraporn Jitprapaikulsan, James P Fryer, Masoud Majed, et al.Annals of Neurology|August 5, 2018
LGI1 and CASPR2 neurological autoimmunity in childrenA Sebastian López-Chiriboga, Christopher Klein, Anastasia Zekeridou, et al.Neurology|January 23, 2023
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum DisorderLaura Cacciaguerra, Pearse Morris, W Oliver Tobin, et al.Ophthalmology|May 3, 2018
Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic NeuritisJiraporn Jitprapaikulsan, John J Chen, Eoin P Flanagan, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody diseaseItay Lotan, John J Chen, Yael Hacohen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 9, 2026
Psychiatric comorbidities cluster early after onset in MOGAD: a cross-sectional comparative study with MS and NMOSDMoritz Niederschweiberer, Cicek Bakir, Nisa Vorasoot, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 11, 2024
Pediatric MOG-Ab-Associated Encephalitis: Supporting Early Recognition and TreatmentNee Na Kim, Dimitrios Champsas, Michael Eyre, et al.The Lancet. Neurology|January 27, 2023
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteriaBrenda Banwell, Jeffrey L Bennett, Romain Marignier, et al.Neurology|May 5, 2025
Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAlessandro Dinoto, Laura Cacciaguerra, Nisa Vorasoot, et al.Annals of Neurology|July 7, 2021
Magnetic Resonance Imaging Correlates of Multiple Sclerosis Immunopathological PatternsImke Metz, Ralitza H Gavrilova, Stephen D Weigand, et al.Pageof 29